IT1405078B1 - Composti per il trattamento di tumori che portano oncoproteine myc deregolate - Google Patents

Composti per il trattamento di tumori che portano oncoproteine myc deregolate

Info

Publication number
IT1405078B1
IT1405078B1 ITTO2010A000539A ITTO20100539A IT1405078B1 IT 1405078 B1 IT1405078 B1 IT 1405078B1 IT TO2010A000539 A ITTO2010A000539 A IT TO2010A000539A IT TO20100539 A ITTO20100539 A IT TO20100539A IT 1405078 B1 IT1405078 B1 IT 1405078B1
Authority
IT
Italy
Prior art keywords
deregolate
oncoproteins
myc
tumors
compounds
Prior art date
Application number
ITTO2010A000539A
Other languages
English (en)
Inventor
Valentina Adami
Viktoryia Sidarovich
Alessandro Quattrone
Original Assignee
Quattrone
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quattrone filed Critical Quattrone
Priority to ITTO2010A000539A priority Critical patent/IT1405078B1/it
Priority to PCT/IB2011/052735 priority patent/WO2011161631A2/en
Priority to EP11735558.6A priority patent/EP2590648A2/en
Priority to US13/806,880 priority patent/US20130203822A1/en
Publication of ITTO20100539A1 publication Critical patent/ITTO20100539A1/it
Application granted granted Critical
Publication of IT1405078B1 publication Critical patent/IT1405078B1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ITTO2010A000539A 2010-06-23 2010-06-23 Composti per il trattamento di tumori che portano oncoproteine myc deregolate IT1405078B1 (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ITTO2010A000539A IT1405078B1 (it) 2010-06-23 2010-06-23 Composti per il trattamento di tumori che portano oncoproteine myc deregolate
PCT/IB2011/052735 WO2011161631A2 (en) 2010-06-23 2011-06-22 Compounds for treatment of tumors bearing deregulated myc oncoproteins
EP11735558.6A EP2590648A2 (en) 2010-06-23 2011-06-22 Compounds for treatment of tumors bearing deregulated myc oncoproteins
US13/806,880 US20130203822A1 (en) 2010-06-23 2011-06-22 Compounds for treatment of tumors bearing deregulated myc oncoproteins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITTO2010A000539A IT1405078B1 (it) 2010-06-23 2010-06-23 Composti per il trattamento di tumori che portano oncoproteine myc deregolate

Publications (2)

Publication Number Publication Date
ITTO20100539A1 ITTO20100539A1 (it) 2011-12-24
IT1405078B1 true IT1405078B1 (it) 2013-12-16

Family

ID=43516832

Family Applications (1)

Application Number Title Priority Date Filing Date
ITTO2010A000539A IT1405078B1 (it) 2010-06-23 2010-06-23 Composti per il trattamento di tumori che portano oncoproteine myc deregolate

Country Status (4)

Country Link
US (1) US20130203822A1 (it)
EP (1) EP2590648A2 (it)
IT (1) IT1405078B1 (it)
WO (1) WO2011161631A2 (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015051447A1 (en) * 2013-10-09 2015-04-16 University Health Network Methods and compositions for treating cancer
KR101579054B1 (ko) * 2014-03-26 2015-12-21 한국원자력의학원 포도필로톡신 아세테이트를 유효 성분으로 포함하는 방사선치료 증진제
CA3037564C (en) * 2017-06-04 2022-10-11 Dun Yang Process for exploiting synthetic lethality based on overexpression of myc oncogene
CN110354121B (zh) * 2019-07-08 2023-05-02 温州医科大学 环吡酮胺在制备治疗肿瘤药物中的应用和包含环吡酮胺的组合药物及用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002323368B2 (en) * 2001-08-23 2006-12-07 The Government Of The United States Of America As Represented By The Secretary, Department Of Health & Human Services Methods of inhibiting formation of vascular channels and profileration using pyridinone derivatives
AU2003251875A1 (en) * 2002-07-15 2004-02-02 Combinatorx, Incorporated Combination therapy for the treatment of neoplasms
WO2010081486A1 (en) * 2009-01-13 2010-07-22 Ingo Schmidt-Wolf Compounds effective against cancer

Also Published As

Publication number Publication date
US20130203822A1 (en) 2013-08-08
WO2011161631A2 (en) 2011-12-29
WO2011161631A3 (en) 2012-03-22
ITTO20100539A1 (it) 2011-12-24
EP2590648A2 (en) 2013-05-15

Similar Documents

Publication Publication Date Title
IL261852B (en) Imidazole-based modified compounds for cancer therapy
LTC2649086I2 (lt) Chimeriniu antigenų receptoriumi modifikuotų ląstelių naudojimas vėžio gydymui
SMT201600293B (it) Composti chimici
SMT201600064B (it) Anticorpi per il trattamento di un cancro esprimente claudina 6
HK1207861A1 (en) Substituted cycloalkenopyrazoles as bub1 inhibitors for the treatment of cancer bub1
DK3289876T3 (da) Forbindelser til behandling af cancer
PT3418281T (pt) Pirazolo[1,5-a]pirimidinas úteis como inibidores da quinase atr para o tratamento de doenças de cancro
DK2504451T3 (da) Fremgangsmåder til at forudsige det kliniske forløb af cancer
DK2753334T3 (da) Fap-aktiverede proteasomhæmmere til behandling af solide tumorer
BR112013010157A2 (pt) inibidores do ibat para o tratamento de doenças do fígado
BR112013014943A2 (pt) compostos úteis para o tratamento de aids
ZA201206479B (en) Compounds for immunoproteasome inhibition
DK3483143T3 (da) Piperidinonderivater som mdm2-inhibitorer til behandlingen af kræft
BR112014000033A2 (pt) compostos para o tratamento de dependência química
BRPI0918178A2 (pt) anticorpos monoclonais para tratamento de câncer
IT1401129B1 (it) Processo per la sintesi di composti benzotiadiazolici
DK2648516T3 (da) Substituerede pyridinon-pyridinylforbindelser
EP2571361A4 (en) PYRAZOLOPYRIMIDINE COMPOUNDS FOR CANCER TREATMENT
DK3275896T3 (da) Fremgangsmåde til at opnå antistoffer
DK2452189T3 (da) Fremgangsmåde til identifikation af forbindelser til behandling af cancer
PL2550296T3 (pl) Przeciwciała monoklonalne w leczeniu nowotworów
EP2590938A4 (en) NEW SULFONAMIDE COMPOUNDS TO INHIBIT THE GROWTH OF TUMORMETASTASES
IL249507A0 (en) Use of anti-il-1a antibodies to treat uveitis
EP2670435A4 (en) USE OF ANTI-DKK1 MONOCLONAL ANTIBODY FOR THE TREATMENT OF LIVER CANCER
EP2608671A4 (en) COMPOUNDS USED IN THE TREATMENT OF CANCER